Swaroopa Chakole

Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe) Wardha, India


  • Research   
    Covid-19 in High Risk Comorbid Patients
    Author(s): Vipul Garg* and Swaroopa Chakole

    Since December 2019, the ongoing epidemic, COVID 19, also known as severe acute respiratory syndrome -Cov-2, has infected over 70 lakh people throughout the globe. Coronavirus are a broad group of viruses that can cause a variety of lung diseases in human beings, from mild to severe. CoV-2, or severe acute respiratory syndrome, is an infective and pathogenic coronavirus that first appeared towards the end of 2019 and has subsequently produced a pandemic of acute respiratory illness known as "coronavirus disease 2019”, which is a global health issues. Its complaints can vary from a simple cough to more extreme disorders like bronchitis, pneumonia, ARDS, MODS, and can be fatal. COVID-19 is known to have rapid and serious advancement in those with already existing health issues, often resulting to death. Individuals with prior history of morbidities, like diabetes mellitus and.. Read More»

    Abstract HTML PDF